Glenmark Pharmaceuticals, a research-led global pharmaceutical company, has announced the strategic appointment of Parviz Dhamodiwalla as its Senior Vice President – Human Resources, effective June 2026. This pivotal role places Dhamodiwalla at the helm of HR operations for Glenmark’s expansive International Formulations Business, encompassing critical markets across North America, Europe, the Asia-Pacific (APAC) region, and Latin America. The appointment underscores Glenmark’s commitment to strengthening its global talent strategy and enhancing its human capital framework to support its ambitious international growth objectives.
The Strategic Mandate: Driving Global HR Excellence for International Formulations
In her new capacity, Parviz Dhamodiwalla is tasked with spearheading the human resources strategy for a critical segment of Glenmark’s global operations. The International Formulations Business is the engine of Glenmark’s global footprint, responsible for the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products in key therapeutic areas such as dermatology, respiratory, and oncology, among others. The geographical breadth of her mandate—spanning developed markets like North America and Europe, and high-growth regions like APAC and Latin America—presents a complex yet strategic challenge.
The role demands a sophisticated understanding of diverse regulatory environments, varied talent landscapes, and distinct cultural nuances. Dhamodiwalla will be instrumental in formulating and implementing HR policies and initiatives that attract, develop, and retain top talent across these regions, fostering a unified yet locally adaptive organizational culture. Her responsibilities will encompass a wide array of HR functions, including talent acquisition, performance management, compensation and benefits, employee relations, organizational development, and leadership succession planning, all aimed at optimizing human capital to drive business performance and innovation in a highly competitive global pharmaceutical market.
A Distinguished Career in Global Human Resources Leadership
Parviz Dhamodiwalla brings an impressive career trajectory spanning over 22 years, marked by significant leadership roles across diverse sectors including pharmaceuticals, healthcare, financial services, and consulting. Her extensive experience is particularly concentrated in critical areas such as talent management, organization design, leadership development, HR business partnering, and people transformation—all essential competencies for navigating the complexities of a multinational pharmaceutical enterprise.
Prior to her appointment at Glenmark, Dhamodiwalla demonstrated her entrepreneurial acumen as the founder and CEO of RuBaSphere Consulting. From its inception in April 2025 until June 2026, her people-first HR consultancy specialized in a comprehensive suite of services including training, coaching, talent and leadership development, HR solutions, and succession planning. This entrepreneurial phase equipped her with a unique perspective on agile HR strategies and client-centric solutions, invaluable for her new corporate leadership role.
Before establishing her consultancy, Dhamodiwalla served as Vice President – Human Resources at The Phoenix Mills, a prominent Indian real estate developer, where she contributed from September 2022 to January 2024. In this role, she was responsible for steering the HR agenda for a large and diverse workforce, gaining experience in a rapidly evolving service sector.
A significant portion of her professional journey was dedicated to Johnson & Johnson, one of the world’s largest and most diversified healthcare companies. For nearly a decade, Dhamodiwalla held several international HR leadership roles within J&J, honing her expertise in managing complex global HR initiatives across various business units. Her tenure at Johnson & Johnson provided her with deep insights into the pharmaceutical and medical device industries, encompassing global talent strategies, organizational effectiveness, and cultural integration across multiple geographies.
Earlier in her career, Dhamodiwalla contributed to Novartis, another pharmaceutical giant, as Head Talent Management & Organisation Design, Global Technical Operations, Pharma. Based in Switzerland, a global hub for pharmaceutical innovation, she held this crucial position from January 2010 to May 2011. This role involved shaping talent strategies and organizational structures for global technical operations, a domain critical for pharmaceutical manufacturing and supply chain excellence.
She commenced her corporate HR career with Standard Chartered Bank, a leading international banking group, where she spent over eight years. From May 2001 to May 2009, her roles at Standard Chartered provided a foundational understanding of HR within a highly regulated global financial services environment, emphasizing areas such as talent acquisition, employee relations, and compliance across diverse markets.
Academically, Parviz Dhamodiwalla is an alumna of the prestigious XLRI Jamshedpur, one of India’s premier management institutes, known for its strong HR programs. She also holds a bachelor’s degree in Economics and Statistics from St Xavier’s College, Mumbai, providing a strong analytical foundation for her career in human resources. This blend of specialized HR education and robust analytical skills underpins her data-driven approach to HR strategy.
Glenmark Pharmaceuticals: A Global Player in Focus
Glenmark Pharmaceuticals, founded in 1977, has evolved into a formidable global pharmaceutical company with a presence in over 80 countries. Known for its research and development capabilities, particularly in novel chemical entities (NCEs) and novel biological entities (NBEs), Glenmark focuses on therapeutic areas such as dermatology, respiratory, oncology, and anti-infectives. The company has successfully launched several innovative products and generics, establishing a strong foothold in both developed and emerging markets.
The International Formulations Business is central to Glenmark’s strategic vision, representing a significant portion of its global revenue and growth potential. This segment relies heavily on robust R&D, efficient manufacturing, effective market access strategies, and, crucially, a highly skilled and adaptable workforce. As the pharmaceutical industry continues to globalize and face increasing competition, the ability to attract, develop, and retain talent becomes a paramount competitive differentiator. Glenmark’s emphasis on global expansion, particularly in specialized and complex therapeutic areas, necessitates a sophisticated HR framework that can support its scientific innovation, commercial success, and operational excellence across diverse geographies.
The Evolving Landscape of International Pharmaceutical HR
The global pharmaceutical industry operates within a dynamic and challenging HR environment. Several macro trends and specific industry demands necessitate a highly strategic and adaptable approach to human resources:
- Global Talent War: The demand for highly specialized talent, including research scientists, clinical development experts, regulatory affairs professionals, and market access specialists, far outstrips supply. Pharmaceutical companies are in a constant battle to attract and retain these critical skills, often competing with biotech startups and other high-tech industries.
- Digital Transformation and Automation: The increasing adoption of AI, machine learning, and automation in drug discovery, clinical trials, and manufacturing processes requires a workforce with new digital skills and a continuous learning mindset. HR must facilitate upskilling and reskilling initiatives to bridge this talent gap.
- Regulatory Complexity: Operating across North America, Europe, APAC, and Latin America means navigating a labyrinth of differing labor laws, healthcare regulations, and employment standards. HR leaders must ensure global compliance while maintaining operational efficiency and employee satisfaction.
- Diversity, Equity, and Inclusion (DE&I): A diverse workforce is increasingly recognized as a driver of innovation and better business outcomes. For a global company like Glenmark, fostering DE&I across varied cultural contexts is crucial, requiring tailored strategies that respect local nuances while upholding global principles.
- Hybrid Work Models and Employee Experience: The post-pandemic era has cemented hybrid and remote work as standard practices. HR must develop policies and technologies that support a flexible workforce, ensure equitable employee experiences, and maintain strong organizational culture and engagement across geographically dispersed teams.
- Leadership Development for a Globalized World: Cultivating leaders who can effectively manage multicultural teams, navigate complex international markets, and drive innovation in a fast-paced environment is critical. This requires sophisticated leadership development programs that focus on global acumen, emotional intelligence, and strategic thinking.
- Succession Planning: Ensuring a robust pipeline of future leaders and critical talent is paramount for long-term sustainability. Strategic HR leaders must identify high-potential employees, provide targeted development, and manage succession across global roles.
- Data-Driven HR: Leveraging HR analytics to inform talent strategies, identify trends, predict attrition, and measure the impact of HR initiatives is becoming indispensable. This shift towards data-driven decision-making helps HR become a more strategic business partner.
Parviz Dhamodiwalla’s extensive background in these very areas positions her uniquely to address these challenges and capitalize on opportunities for Glenmark. Her experience in organization design, for instance, will be critical in structuring agile teams that can adapt to rapid market changes and regulatory shifts in different regions. Her expertise in talent management and leadership development will be vital in cultivating a high-performing workforce capable of driving Glenmark’s international growth.
Strategic Implications for Glenmark’s Global Talent Agenda
Dhamodiwalla’s appointment is poised to have significant strategic implications for Glenmark’s international talent agenda. Her leadership is expected to bring a renewed focus on several key areas:
Firstly, a more integrated and harmonized global HR framework. While local adaptation is crucial, a consistent global strategy for talent acquisition, performance management, and employee development can foster a stronger, more unified corporate identity across Glenmark’s diverse international operations. Dhamodiwalla’s global experience with companies like Johnson & Johnson and Novartis will be invaluable in achieving this balance.
Secondly, an acceleration of leadership development programs tailored for an international context. As Glenmark expands its global footprint, the need for leaders who possess cross-cultural competence, strategic agility, and a deep understanding of international markets becomes paramount. Her background in leadership development suggests a potential focus on building a robust pipeline of globally-minded leaders capable of driving the company’s ambitious growth targets.
Thirdly, an enhanced emphasis on data-driven HR solutions. With her consulting background and experience across data-intensive sectors, Dhamodiwalla is likely to champion the use of HR analytics to inform strategic decisions, optimize talent allocation, and measure the effectiveness of HR programs. This will enable Glenmark to make more informed choices about its human capital investments.
Furthermore, her expertise in people transformation suggests a proactive approach to fostering an inclusive and engaging work environment that attracts and retains top talent. In the highly competitive pharmaceutical sector, a strong employer brand, underpinned by a positive employee experience, is a crucial differentiator. Dhamodiwalla will likely play a key role in shaping Glenmark’s culture to support innovation, collaboration, and ethical practices across its international operations.
Official Responses and Forward Vision
While specific official statements regarding Dhamodiwalla’s appointment were not provided, the strategic nature of the role and the caliber of the individual joining Glenmark allow for plausible inferences about the company’s perspective and Dhamodiwalla’s initial vision.
A senior executive at Glenmark Pharmaceuticals, perhaps the CEO or the Head of International Formulations Business, would likely express profound enthusiasm for Dhamodiwalla’s arrival. Such a statement might emphasize: "We are delighted to welcome Parviz Dhamodiwalla to Glenmark as our Senior Vice President – Human Resources for our International Formulations Business. Her extensive global experience across diverse industries, particularly in pharmaceuticals and healthcare, and her proven track record in talent management and organizational design, are precisely what we need to elevate our human capital strategy. Her leadership will be instrumental in nurturing our global talent, fostering an inclusive culture, and ensuring our HR initiatives are perfectly aligned with our ambitious international growth plans across North America, Europe, APAC, and Latin America."
From Parviz Dhamodiwalla’s perspective, her statement would likely reflect her excitement for the new challenge and her strategic priorities. She might convey: "I am incredibly excited to join Glenmark Pharmaceuticals at such a pivotal time for its international expansion. The opportunity to lead HR for the International Formulations Business across such dynamic and diverse markets is a compelling challenge. My focus will be on building a robust, agile, and future-ready HR framework that empowers our employees, attracts the best talent, and drives sustainable business growth. I look forward to working closely with the leadership team to cultivate a high-performance culture that supports Glenmark’s mission of delivering innovative and affordable medicines globally."
Conclusion
Parviz Dhamodiwalla’s appointment as Senior Vice President – Human Resources for Glenmark’s International Formulations Business marks a significant strategic move for the pharmaceutical giant. Her profound global experience, coupled with her specialized expertise in critical HR domains, positions her as a key architect in shaping Glenmark’s human capital strategy for its diverse international operations. As the pharmaceutical industry navigates complex talent challenges, technological shifts, and regulatory landscapes, Dhamodiwalla’s leadership is expected to fortify Glenmark’s ability to attract, develop, and retain the talent necessary to drive innovation, sustain growth, and reinforce its position as a leading global pharmaceutical player in the years to come. Her strategic vision will be crucial in ensuring that Glenmark’s people strategy remains a core competitive advantage in the global arena.
